Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide.
Ulrichs
K
K
Institute of Immunology, Medical School, University of Kiel, Germany.
Kaitschick
J
J
Bartlett
R
R
Müller-Ruchholtz
W
W
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis*; D000917:Antibody Formation / Q000187:drug effects*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D016219:Immunotherapy, Adoptive; D007555:Isoxazoles / Q000494:pharmacology*; D000077339:Leflunomide; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology; D051381:Rats; D011917:Rats, Inbred Lew
D000910:Antibodies, Heterophile; D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide